Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The ability to automatically transfer data to clinicians and receive timely guidance in therapy adjustments through remote and in-office consults can positively impact patients' perceptions about quality of care, which is positively associated with clinical outcomes. We assessed the impact of using the Accu-Chek Connect diabetes management system on treatment satisfaction, diabetes distress, and glycemic control in adults with type 1 diabetes and insulin-treated type 2 diabetes. SUBJECTS AND METHODS: This 6-month, prospective, multicenter, single-arm study assessed the impact of using the system on treatment satisfaction and glycemic control among 87 adults with insulin-treated diabetes (multiple daily insulin injections and basal only), with 8.8% ± 1.6% glycated hemoglobin (HbA1c) at baseline. The Diabetes Treatment Satisfaction Questionnaire-status (DTSQs) and Diabetes Distress Scale (DDS) were administered at baseline, and the Diabetes Treatment Satisfaction Questionnaire-change (DTSQc) and DDS at 6 months. Changes in HbA1c, average blood glucose (BG), and other metrics were also assessed. RESULTS: Improvements in DTSQc scores were observed at 6 months with a total mean (standard deviation) score of 14.3 ± 5.1. Significant reductions in total mean DDS scores from baseline to 6 months were also observed, from 2.0 ± 0.8 to 1.7 ± 0.7, P < 0.0001. A significant reduction in regimen-related distress was notable, from "moderate distress" (2.4 ± 1.0) to "not distressed" (1.9 ± 0.9), P < 0.0001). Significant reductions in mean HbA1c (-0.9 ± 1.6, P < 0.0001) and mean BG (-24.8 ± 50.8, P < 0.0001) were observed. CONCLUSIONS: Use of the Accu-Chek Connect diabetes management system is associated with increased treatment satisfaction and improved glycemic control among individuals with insulin-treated diabetes. NCT02600845 ( www.clinicaltrials.gov ).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
Achievement of Goals in U.S. Diabetes Care, 1999–2010
Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1213829 · Cited by 979 · cited 1×
“0%.(23,24) A major contributor to poor glycemic control is difficulty adhering to prescribed self-management regimens.”
BackgroundLiang, X., Wang, Q., Yang, X., Cao, J., Chen, J., Mo, X., Huang, J., Wang, L., & Gu, D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03180.x · Cited by 515
Holmen, H., Torbjørnsen, A., Wahl, A. K., Jenum, A. K., Småstuen, M. C., Årsand, E., & Ribu, L. (2014) · JMIR mHealth and uHealth · doi:10.2196/mhealth.3882 · Cited by 294
Faridi, Z., Liberti, L., Shuval, K., Northrup, V., Ali, A., & Katz, D. L. (2008) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2007.00881.x · Cited by 217
Clinical Inertia Contributes to Poor Diabetes Control in a Primary Care Setting
Ziemer, D. C., Miller, C. D., Rhee, M. K., Doyle, J. P., Watkins, C., Cook, C. B., Gallina, D. L., El-Kebbi, I. M., Barnes, C. S., Dunbar, V. G., et al. (2005) · The Diabetes Educator · doi:10.1177/0145721705279050 · Cited by 208
Longitudinal effects of medication nonadherence on glycemic control
Egede, L. E., Gebregziabher, M., Echols, C., & Lynch, C. P. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014526362 · Cited by 146
Franciosi, M., Lucisano, G., Pellegrini, F., Cantarello, A., Consoli, A., Cucco, L., Ghidelli, R., Sartore, G., Sciangula, L., Nicolucci, A., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03268.x · Cited by 137
Bosi, E., Scavini, M., Ceriello, A., Cucinotta, D., Tiengo, A., Marino, R., Bonizzoni, E., Giorgino, F., & on behalf of the PRISMA Study Group (2013) · Diabetes Care · doi:10.2337/dc13-0092 · Cited by 105
Cited by
Qudah, B., & Luetsch, K. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2019.01.021 · Cited by 200
Bergenstal, R. M., Johnson, M., Passi, R., Bhargava, A., Young, N., Kruger, D. F., Bashan, E., Bisgaier, S. G., Isaman, D. J. M., & Hodish, I. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30368-x · Cited by 88
Steenkamp, D., Eby, E. L., Gulati, N., & Liao, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821997923 · Cited by 33
Kumbara, A. B., Iyer, A. K., Green, C. R., Jepson, L. H., Leone, K., Layne, J. E., & Shomali, M. (2023) · JMIR Diabetes · doi:10.2196/47638 · Cited by 29
“This was also seen in studies with multiple intervention types [7] that used connected BGMs [8] and in a digital diabetes management program that offers personalized educational content [9].”
Metadata
- Authors
- Mora, P., Buskirk, A., Lyden, M., Parkin, C. G., Borsa, L., & Petersen, B.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2017-12
- Volume
- 19
- Issue
- 12
- Pages
- 715-722
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2763169296
- Cited by
- 41
- References
- 12
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.